Intel Corporation R&D Expense: 2.31B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
INTC R&D Expense Rankings
| Overall | 0th percentile | 1870 of 1873 |
| Sector | 0th percentile | 687 of 687 in Technology |
| Industry | 0th percentile | 26 of 26 in Semiconductor - Broad Line |
INTC R&D Expense Range, Past 5 Years
| Minimum | 60.82M | Mar 1987 |
| Maximum | 1.56B | Mar 2006 |
| Average | 598.32M |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these INTC related companies
INTC News
Cisco Stock Turning Around Faster Than Company’s Results; Other Tech Giants Growing Faster http://stks.co/2LwN $CSCO $GOOG $AAPL $INTC
about 2 days ago by ycharts
about 2 days ago by ycharts
YCHARTS DIVIDEND DAILY: Microsoft and Intel, Underappreciated, Offer Good Yield and Rock-Solid Financials http://stks.co/2LtP $MSFT $INTC
about 2 days ago by ycharts
about 2 days ago by ycharts
$SPY 54 NR7 Day Alerts for the S&P 500 Stocks. $WHR bull flag. $HON coiling action. $INTC in trading range. http://stks.co/2L2N
about 3 days ago by tradewithpete
about 3 days ago by tradewithpete
News related to $INTC: 'NY attorney general ends lawsuit against Intel' http://stks.co/2L1U
about 3 days ago by TradeBot
about 3 days ago by TradeBot
RT @ivanhoff Intel has one of the best risk/reward bullish looking charts here with $27 being the tipping point $INTC http://stks.co/2Kms
about 3 days ago by wallstreetbean
about 3 days ago by wallstreetbean
Intel has one of the best risk/reward bullish looking charts here with $27 being the tipping point $INTC http://chart.ly/iilbvl4
about 3 days ago by ivanhoff
about 3 days ago by ivanhoff
RT @techinsidr With a $461.31B market cap, $AAPL is now worth more than $GOOG $INTC and $CSCO combined.
about 3 days ago by princebhojwani
about 3 days ago by princebhojwani
RT @techinsidr With a $461.31B market cap, $AAPL is now worth more than $GOOG $INTC and $CSCO combined
about 3 days ago by koffeedragon
about 3 days ago by koffeedragon
$IBM $INTC $BA $GE are on the upward trends. http://stks.co/2KSO
about 3 days ago by stocktrendcharts
about 3 days ago by stocktrendcharts
$INTC http://stks.co/2Jnu Flagging below 27. Trigger 27.01. Targeting 28.41. Stop 26.3.
about 4 days ago by tk993
about 4 days ago by tk993
RT @bclund "Just so weird to have $INTC and $MSFT coming back into possible trading plays" $INTC is on the IBD50 list, a growth stock again!
about 4 days ago by MorrowM
about 4 days ago by MorrowM
Big tech is back in vogue - retro charts forming in $CSCO, $INTC, $MSFT, $IBM
about 4 days ago by mktmorph
about 4 days ago by mktmorph
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| INTC | 26.70 | -0.17 | -0.61% | 135.93B |
| KMB | 71.56 | -0.32 | -0.45% | 28.20B |
| AIG | 26.66 | -0.69 | -2.52% | 50.60B |
| TMK | 47.20 | 0.53 | 1.14% | 4.81B |
| ANR | 21.04 | -1.36 | -6.07% | 4.76B |
| APA | 105.13 | -1.55 | -1.45% | 40.36B |
| URRE | 0.95 | -0.08 | -7.73% | 88.89M |
| CYTK | 1.18 | -0.01 | -0.84% | 85.29M |
| BMY | 31.90 | -0.09 | -0.28% | 54.06B |
| GSK | 44.75 | -0.31 | -0.69% | 114.07B |
